Due to the inconsistent results of current studies, more further studies are required to fully understand the role of irisin in metabolic control and its potential as a biomarker for IR in PCOS. As expected, PCOS women in this study had significantly higher cases of clinical hyperandrogenism and oligomenorrhoea compared to controls. The gene discussed is FNDC5; the disease is polycystic ovary syndrome.